Pharmacy Podcast Network

Continuous Glucose Monitoring:Understanding the Pharmacist’s Role in Patient Education and Improving Outcomes in Diabetes Management   Objectives  Describe the use of continuous glucose monitoring (CGM) in diabetes management and ADA/AACE recommendations Recognize the role of the pharmacist in providing education related to the use of CGM devices and interpreting CGM data Faculty Disclosures Curtis L. Triplitt, PharmD, has the following relevant financial relationships with commercial interests to disclose: Consultant: Bayer Speaker’s Bureau: Eli Lilly, NovoNordisk Susan Cornell, PharmD, CDCES, FAPhA, FADCES, has the following relevant financial relationships with commercial interests to disclose: Speaker’s Bureau: Novo Nordisk, Inc. Other Support: Advanced Practitioner Advisory Board- Novo Nordisk, Inc. PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for .5 contact hours of knowledge-based credit. This activity is supported by an independent educational grant from Abbott Diabetes Care Inc. Learn more here: https://www.pharmacytimes.org/on-demand/continuous-glucose-monitoring-understanding-the-pharmacists-role-in-patient-education-and-improving-outcomes-in-diabetes-management Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The UnScripted Podcast, episode one is a conversation with Cecelia Byers, PharmD Specialty Pharmacy Clinical Product Manager and Dr. Andrew Mellin, VP, Chief Medical Information Officer with Surescripts. Today we have a interesting discussion on how the process of prescribing and dispensing specialty medication relies on antiquated technology: fax machines, paper forms and phone calls and how Surescripts is transforming the process for prescribing specialty medications Learn more: https://surescripts.com/resources/specialty-medications This podcast is a call to action on the broader healthcare industry to standardize digital processes to help remove admin burden We talk about the need for system-wide streamlining of data between providers, patients, and pharmacies not only to ensure all the necessary patient information for specialty prescriptions is automatically available, but to also prepare for the influx of new specialty treatments. We discuss the electronic solutions for manual processes can address process challenges, such as manual collection and receipt of enrollment data, and prior authorization delays. We discuss the data uncovered in the 2020 specialty pharmacists survey Specialty pharmacists have an incredibly difficult job, given the complex nature of specialty medications and the added burden of a healthcare system disrupted by the COVID-19 pandemic. Yet the ability to touch patients’ lives is what gives meaning to specialty pharmacists’ work. Find more info here: https://surescripts.com/resources/specialty-medications Cecelia Byers, PharmD, Specialty Pharmacy Clinical Product Manager at Surescripts, recently joined the National Association of Specialty Pharmacy Podcast to discuss the challenges that specialty pharmacists face and how technology providers like Surescripts help specialty pharmacists keep the focus on patients. https://surescripts.com/news-center/intelligence-in-action/specialty-medications/podcast-helping-specialty-pharmacists-keep-focus-on-patients See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

This Podcast Series is about Pharmacists & Physicians collaborating on the proper & humane usage of pain managment strategies, the usage of opioids, and evidence-based medication therapy management practices.  Each day, more than 130 people die from opioid overdoses. Opioids are a class of drugs that include prescription pain relievers like oxycodone. They also include illegal drugs like heroin. In 2019, 1.6 million Americans had an opioid addiction. This is also known as opioid use disorder. Yet effective medications—like buprenorphine, methadone, and naltrexone—are prescribed to only a fraction of people with opioid use disorder. Patients often receive such medications in an opioid treatment program. Methadone, for example, can only be given in a certified treatment program. Primary care physicians can apply for a waiver to prescribe buprenorphine. However, less than 10% of U.S. primary care providers have a buprenorphine waiver. Given the limited number of patients that each physician can treat, involving pharmacists in opioid treatment may improve access. Part one features two executives from PROP - Physicians for Responsible Opioid Prescribing to se the stage for the podcast collaborative and helping pharmacists and physicians to work together more effectively through the expertise and experiences of our doctors.  Today's Guests:  Jane C. Ballantyne, MD, FRCA President, PROP Professor, Anesthesiology and Pain Medicine University of Washington  Andrew Kolodny, MD Vice President, Federal Affairs, PROP; Medical Director, Opioid Policy Research Collaborative, Heller School for Social Policy & Management Brandeis University Learn more at: http://www.supportprop.org/  #PROPRx See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

It's time to rethink how you remain competitive in a digitally transformed marketplace. The Digital Revolution has created a radical paradigm shift in the way the world of business works - are you prepared?  We are at the beginning of an unprecedented inflection point in the development of civilization—the transition from the first human epoch where centralized hierarchies that leveraged individual intelligence were the basis of social organization to the second human epoch whose social structures will be highly sophisticated distributed networks capable of rapidly leveraging human and artificial collective intelligence.  Guest speaker is - Rod Collins  Author & Keynote Speaker and Host of the Salt Flats Innovation Podcast See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

It's the GameChangers' Birthday! This episode is a rapid review of a few subjects to celebrate the first year of GameChangers. From oral iron administration to the use of metronidazole with alcohol or serotonin syndrome, this episode has all the ingredients for a celebration! GameChangers' host, Geoff Wall, just released new music! Check out his latest EP here: https://open.spotify.com/artist/0J26ngHZz2cf6mQR3UiEHW?827= or wherever you listen to music! Reference: Stoffel NU, Cercamondi CI, Brittenham G, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol. 2017 Nov;4(11):e524-e533. doi: 10.1016/S2352-3026(17)30182-5. Epub 2017 Oct 9. PMID: 29032957. Kaundal R, Bhatia P, Jain A, et al. Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemia. Ann Hematol. 2020 Jan;99(1):57-63. doi: 10.1007/s00277-019-03871-z. Epub 2019 Dec 6. PMID: 31811360. Visapää JP, Tillonen JS, Kaihovaara PS, et al. Lack of disulfiram-like reaction with metronidazole and ethanol. Ann Pharmacother. 2002 Jun;36(6):971-4. doi: 10.1345/aph.1A066. PMID: 12022894. Orlova Y, Rizzoli P, Loder E. Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome. JAMA Neurol. 2018 May 1;75(5):566-572. doi: 10.1001/jamaneurol.2017.5144. PMID: 29482205; PMCID: PMC5885255. CPE details for GameChangers Podcast April 2021 Learning Objective: Discuss the evidence-based dosing of oral iron supplementation. 0107-0000-21-158-H01-P 0.2 CEU/2 Hrs (Knowledge) Initial Release Date: 04/06/21 Expiration Date: 03/02/24 Additional CPE information is located at https://www.ceimpact.com/podcast  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Queen's Gambit, a Netflix mini-series released in 2020, featured an unlikely cast member alongside Anya Taylor-Joy: Librium, aka Chlordiazepoxide. Uncover the true history of the very first benzodiazepine and join Shane, Mickey and Cal as we analyze the realism of its portrayal in this excellent mini-series. This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics! Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at pharmonization@gmail.com. PLEASE READ: Shane, Cal and Jill are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health, A special thanks to Kelly Kerr for creating the music used in the intro and outro. Additional music from Fesliyan Studios See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The  COVID-19 pandemic exponentially accelerated adoption of virtual care and heightened consumer expectations, which caused health systems to reimagine their role in virtual care. As a result, adoption of virtual care has empowered health systems to move beyond siloed applications to a comprehensive, whole-person approach that consumers will need across their healthcare journey.     See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Chapter 3 of 3  Featuring: Allegheny Health Network Pharmacy Services  Pharmacy Care Continuum Patient centered care across the patient care continuum…. Starting out as pilots, scaling, and linking From bedside to the home & community pharmacy integration – reducing costs and limiting readmissions Guests: Laura (McCoy) Mark, PharmD - Vice President, Pharmacy Mike Korczynski, PharmD Ed Seidl, PharmD - Director of Pharmacy Clinical Services This podcast series is sponsored by Omnicell.  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

"The only way to change the status-quo is to get off your ass and change it."  Dave Marley, Marley Drug:  It's not easy but it's possible to fight the 3 largest PBMs in your local community with your pharmacy services. Listen into this podcast & share with other pharmacy owners for several ideas on beating the PBMs in Community Pharmacy.  Thank you ApproRx & P.U.T.T. for sponsoring this podcast webinar.   Here's the back-drop information on Marley Drug & Medicure:  https://www.medicure.com/about  Work with Medicure today:  Neal Owens nowens@medicure.com  IN A RARE MOVE, A DRUG MANUFACTURER WILL BYPASS THE TRADITIONAL APPROACH AND PROVIDE ACCESS TO AFFORDABLE MEDICATIONS ACROSS THE UNITED STATES VIA MARLEY DRUG’S ESTABLISHED MAIL ORDER PHARMACY.   With licensing to deliver prescription drugs to all 50 states, Washington D.C. and Puerto Rico, and with an established vision to deliver low cost generic medications, Marley Drug Pharmacy was the natural choice for like-minded Canadian drug manufacturer, Medicure Inc., to further expand distribution of its products within the United States, included its branded statin, Zypitamag® (pitavastatin).   The acquisition allows Medicureto bypass wholesalers and pharmacy benefit managers (PBMs), in an effort to reduce consumer drug costs and provide patients across the U.S. easier access to Zypitamag®, which was extremely difficult for patients and physicians to access because of restrictions and high co-pays dictated by insurers and PBMs. Through Marley Drug Pharmacy, Medicurecan now deliver Zypitamag® to patients in every U.S. state without customers needing to use their insurance, or worry if the prescription will be covered. Medicurecan also provide Zypitamag® at a lower price overall, and a fraction of the cash price of a leading branded statin Livalo® (pitavastatin). As a manufacturer, Medicureintends to provide other branded medications using a similar approach, in addition to extremely low cost generic medications. “It’s a perfect and responsible transition for Marley Drug,” said Dr. David Marley, CEO & President of Marley Drug. “Medicureshares our moral mission to cut drug costs for consumers. Since 2012 we have offered Marley’s Extended Supply Generic Drug Program, which was designed to battle the skyrocketing costs of name-brand drugs, and offer patients affordable alternatives, without increasing co-pays or limiting access to popular generics.  We worked hard to acquire permits in every state.  Now Medicurecan offer Zypitamag® from coast to coast at a fraction of the cost, without the hassle of PBMs and wholesalers.”  “Medicure and Marley Drug have the same vision. We want to deliver safe, efficacious and cost-effective medicines that benefit patients and healthcare providers. Our goal is to increase patient access to Zypitamag® while keeping the process and pricing as simple as possible. Through Marley Drug Pharmacy, we can now provide these benefits regardless of insurance or location,” said Dr. Albert Friesen, CEO of Medicure. “There will be no changes to the hours, location or to the great staff and customer service that Marley has built, and look to hire more staff as business grows. Dave Marley will remain a member of the leadership team, and we want Marley Drug to remain a trusted business within the community, and hopefully, this is a game-changing approach that gains attention nationwide.” Thanks RxSafe for Sponsoring this episode:  RxSafe.com  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode we are joined by a very special guest, Jill Murphy from Pharmacy Focus Podcast, to discuss some old-timey medical treatments and how they've evolved over time. From the Iron Lung to the Clap, we hope you enjoy these four antiquated medical treatments. This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics! Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at pharmonization@gmail.com. PLEASE READ: Shane, Cal and Jill are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health, A special thanks to Kelly Kerr for creating the music used in the intro and outro. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices